Transgene Biotek Share Price
22 Oct, 2026 9:32 AM (IST)
Transgene Biotek Performance
- Today's Low
- ₹2
- Today's High
- ₹3
- 52 Week Low
- ₹2
- 52 Week High
- ₹4
- Open Price₹2
- Previous Close₹2
- Volume6,287
- 50 DMA₹2.70
- 100 DMA₹2.80
- 200 DMA₹3.00
Transgene Biotek Chart
Investment Returns
- Over 1 Month -6.3%
- Over 3 Month -16.78%
- Over 6 Month -15.38%
- Over 1 Year -41.3%
Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!
Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -11.9
- PEG Ratio
- 0.5
- Market Cap Cr
- 19
- P/B Ratio
- 2.4
- Average True Range
- 0.2
- EPS
- -0.2
- Dividend Yield
- 0
- MACD Signal
- -0.1
- RSI
- 42.87
- MFI
- 38.06
Latest Stock News Updates
Appointment of Statutory Auditors to fill the Casual Vacancy The Board of Directors, based on the recommendation of the Audit Committee, has approved the appointment of M/s. Eswara Rao & Co., Chartered Accountants (Firm Registration No. 000816S), represented by Ms. Karra Pranavi, Partner (Membership No. 232994), as the Statutory Auditors of the Company to fill the casual vacancy arising due to the resignation of M/s. Vasavi & Co., Chartered Accountants, subject to the approval of the members of the Company at a general meeting, in accordance with the applicable provisions of the Companies Act, 2013. The Board took note of the consent letter, eligibility certificate and other applicable confirmations received from the proposed Statutory Auditors.
- BSE India
- 1 week 4 days ago
Statement of Deviation & Variation, 30-09-2026.
- BSE India
- 2 weeks 4 days ago
Compliance -57(5) Intimation after the end of quarter
- BSE India
- 2 weeks 4 days ago
Transgene Biotek Financials
Transgene Biotek Technicals
EMA & SMA
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹2.60
- 50 Day
- ₹2.70
- 100 Day
- ₹2.80
- 200 Day
- ₹3.00
Resistance and Support
- R3 2.70
- R2 2.60
- R1 2.50
- S1 2.40
- S2 2.30
- S3 2.20
Transgene Biotek Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-10-10 | Others | Inter alia, (1) To consider and approve the appointment of M/s. Eswara Rao & Co., Chartered Accountants, Firm Registration No. 000816S, as the Statutory Auditors of the Company. |
| 2026-08-07 | Quarterly Results & Others | |
| 2026-05-29 | Audited Results | |
| 2026-02-13 | Quarterly Results | |
| 2025-11-14 | Quarterly Results |
About Transgene Biotek
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc View More- NSE Symbol
- TRABI
- BSE Symbol
- 526139
- ISIN
- INE773D01018
Similar Stocks to Transgene Biotek
Popular Stocks
Transgene Biotek FAQs
Transgene Biotek share price is ₹2 As on 22 October, 2026 | 09:27
The Market Cap of Transgene Biotek is ₹19.2 Cr As on 22 October, 2026 | 09:27
The P/E ratio of Transgene Biotek is -11.9 As on 22 October, 2026 | 09:27
The PB ratio of Transgene Biotek is 2.4 As on 22 October, 2026 | 09:27
The 52 week High & Low of Transgene Biotek is ₹4.3/₹1.8 respectively As on 22 October, 2026 | 09:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.